PD-L1

You have access
Co-expression of PD1/PD-L1 on Tumor Cells Is Involved in the Regulation of Cell Proliferation
YASUNARI NAGASAKI, HIROMICHI YAMANE, MASAMI TAKEYAMA, NOBUAKI OCHI, AYAKA MIMURA, YOKO KOSAKA, NARUHIKO ICHIYAMA, TATSUYUKI KAWAHARA, HIDEKAZU NAKANISHI, AKIO HIRAKI and NAGIO TAKIGAWA

Anticancer Research December 2025, 45 (12) 5341-5350; DOI: https://doi.org/10.21873/anticanres.17872
You have access
Effect of Tissue Sample Type on The Evaluation of PD-L1 (SP142) Expression in Breast Cancer
TAKESHI USUI, MASAFUMI SHIMODA, KAORI ABE, NANAE MASUNAGA, MASAMI TSUKABE, TETSUHIRO YOSHINAMI, YOSHIAKI SOTA, TOMOHIRO MIYAKE, TOMONORI TANEI and KENZO SHIMAZU

Anticancer Research December 2025, 45 (12) 5587-5594; DOI: https://doi.org/10.21873/anticanres.17893
You have access
Stratification by PD-L1 TPS in Advanced NSCLC With Low PD-L1 Expression for Optimizing Immunotherapy
TAKAFUMI FUKUI, SUYA HORI, YUKIHISA HATAKEYAMA, TATSUNORI KIRIU, KANOKO MATSUMURA, NANAKO MIWA, MASAHIRO KATSURADA, KEIKO OKUNO, SHO YOSHIMURA and MOTOKO TACHIHARA

Anticancer Research September 2025, 45 (9) 3859-3875; DOI: https://doi.org/10.21873/anticanres.17745
You have access
Clinical Significance of PD-L1, LAG3, and VISTA in Patients With Poorly Cohesive Cell Gastric Cancer
YUN JI LEE, JIN HO BAEK, JONG GWANG KIM, KI BUM PARK, JI YEON PARK, OH KYOUNG KWON, AN NA SEO, MOON SIK KIM and BYUNG WOOG KANG

Anticancer Research September 2025, 45 (9) 3939-3951; DOI: https://doi.org/10.21873/anticanres.17752
You have access
Neoadjuvant Chemoradiotherapy Enhances Tumor PD-L1 Expression in Pancreatic Cancer
KANECHIKA DEN, TAKASHI MURAKAMI, RYUSEI MATSUYAMA, KENTARO MIYAKE, YUKI HOMMA, YASUHIRO YABUSHITA, RYUTARO MORI, YUKIHIKO HIROSHIMA, IKUMA KATO and ITARU ENDO

Anticancer Research April 2025, 45 (4) 1731-1747; DOI: https://doi.org/10.21873/anticanres.17554
You have access
Tissue Expression and Plasma Soluble PD-L1 Levels in Patients With Endometrial Cancer
EMMANUEL KONTOMANOLIS, ANTONIOS KOUTRAS, ACHILLEAS G. MITRAKAS, GRIGORIOS TRYPSIANIS, KONSTANTINOS NIKOLETTOS, PANAGIOTIS TSIKOURAS, NIKOLAOS NIKOLETTOS, ALEXANDRA GIATROMANOLAKI and MICHAEL KOUKOURAKIS

Anticancer Research December 2024, 44 (12) 5525-5530; DOI: https://doi.org/10.21873/anticanres.17378
Open Access
Antitumor Potential of Guttiferone E Combined With Carboplatin Against Osimertinib-resistant H1975 Lung Cancer Through Apoptosis
AAKASH NATHANI, ISLAUDDIN KHAN, MATHEUS HIKARU TANIMOTO, JENNYFER ANDREA ALDANA MEJÍA, ALINE MAYRINK DE MIRANDA, ARUN RISHI, SATYANARAYAN DEV, JAIRO KENUPP BASTOS and MANDIP SINGH

Anticancer Research October 2024, 44 (10) 4175-4188; DOI: https://doi.org/10.21873/anticanres.17248
You have access
MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma
MINJI KWON, DAYEON LIM, JAYEON PARK, WORLD GIL, JIWOO JUNG, SUYEON JUNG, CHAEEON KIM, MINJEONG GO, YE HWANG CHEONG, HEE SUN PARK, YONG-BIN EOM and SIN-AYE PARK

Anticancer Research October 2024, 44 (10) 4283-4299; DOI: https://doi.org/10.21873/anticanres.17258
Open Access
Contribution of Immunoscore to Survival Prediction in Pancreatic Ductal Adenocarcinoma
HARUKI MORI, TORU MIYAKE, HIROMITSU MAEHIRA, MASANORI SHIOHARA, HIROYA IIDA, NOBUHITO NITTA and MASAJI TANI

Anticancer Research October 2024, 44 (10) 4483-4492; DOI: https://doi.org/10.21873/anticanres.17277
You have access
PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC
INSU KIM, SUN HA CHOI, SHIN YUP LEE, SEUNG SOO YOO, JI EUN PARK, KYEONG-CHEOL SHIN, JONG GEOL JANG, KYUNG SOO HONG, YONG SHIK KWON, SUN HYO PARK, KEUM-JU CHOI, CHI YOUNG JUNG, MI-HYUN KIM, SOO HAN KIM, HEE YUN SEOL, JEHUN KIM, JIN-HAN PARK, TAE HOON KIM, JUNG SEOP EOM and JUNE HONG AHN

Anticancer Research October 2024, 44 (10) 4505-4516; DOI: https://doi.org/10.21873/anticanres.17279

Main menu

User menu

Search

PD-L1

Pages